ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMUC EOM Pharmaceutical Holdings Inc (PK)

0.18395
0.02895 (18.68%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,100
Bid Price 0.15
Ask Price 0.1979
News -
Day High 0.1979

Low
0.0182

52 Week Range

High
0.40

Day Low 0.18395
Company Name Stock Ticker Symbol Market Type
EOM Pharmaceutical Holdings Inc (PK) IMUC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02895 18.68% 0.18395 10:52:40
Open Price Low Price High Price Close Price Prev Close
0.1979 0.18395 0.1979 0.155
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3 5,100 $ 0.184228 $ 940 - 0.0182 - 0.40
Last Trade Time Type Quantity Stock Price Currency
10:52:40 85 $ 0.1879 USD

EOM Pharmaceutical Holdings Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 20.84M 113.27M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

EOM Pharmaceutical (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IMUC Message Board. Create One! See More Posts on IMUC Message Board See More Message Board Posts

Historical IMUC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.15750.19790.1550.18195749250.0264516.79%
1 Month0.220.220.110.16501442,313-0.03605-16.39%
3 Months0.250.300.01820.20093964,207-0.06605-26.42%
6 Months0.37790.39990.01820.23582523,167-0.19395-51.32%
1 Year0.3480.400.01820.25422143,919-0.16405-47.14%
3 Years0.4850.940.01820.44552866,504-0.30105-62.07%
5 Years0.020.980.0120.109182734,0080.16395819.75%

EOM Pharmaceutical (PK) Description

The Company is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Our development pipeline consists of multiple programs and clinical indications at various stages of development. Our portfolio currently consists of two product candidates: EOM613 and EOM147.

Your Recent History

Delayed Upgrade Clock